Back to results
US 2023/0414496 A1Published application
Biodegradable polymer-nanoparticle based implants for ocular drug delivery
OwnerRupak Banerjee, Soumyarwit Manna +1inventors
InventorsRUPAK BANERJEE, SOUMYARWIT MANNA, JAMES AUGSBURGER
Life of this patent
Estimating the term…
Abstract
A biodegradable intravitreal implant that provide sustained release of hydrophilic therapeutic agents and methods of making and using the same to treat various ocular disorders.
Claims30
A biodegradable intravitreal implant for sustained release of a hydrophilic therapeutic agent, comprising of:
- a lyophilized core comprising a porous hydrophilic polymer matrix forming a swellable polymeric core;
- a hydrophilic therapeutic agent distributed throughout said lyophilized core at a desired concentration;
- a smooth, non-porous, bio-degradable hydrophobic polymer coating uniformly disposed about the core;
- and
- a plurality of liposomal nanoparticles encapsulating said therapeutic agent;
- wherein,
- said desired concentration of said hydrophilic therapeutic agent is in a range of 10-40% by weight;
- said nanoparticles are non-metallic nanoparticles;
- and
- said biodegradable intravitreal implant is ophthalmically compatible in the eye.
7 more elements
A process for making a biodegradable intravitreal implant for sustained release of a hydrophilic therapeutic agent, the process comprising:
- mixing a hydrophilic therapeutic agent with a hydrophilic polymer matrix;
- injecting the mixture into medical grade chemically inert flexible tubing;
- lyophilizing the tubing containing the mixture to obtain hydrophilic therapeutic agent-hydrophilic polymer fibers;
- extracting the hydrophilic therapeutic agent-hydrophilic polymer fibers from the tubing;
- cutting the hydrophilic therapeutic agent-hydrophilic polymer fibers into a desired implant length to form a lyophilized core;
- dip-coating the core into a hydrophobic coating solution, the hydrophobic coating solution having a concentration;
- drying the coated core to yield a biodegradable sustained release intravitreal implant having a degradable hydrophobic polymer coating disposed about a core, the coating having a thickness and being permeable to the therapeutic agent;
- injecting the hydrophilic therapeutic agent in a hydrophobic polymer shell;
- double emulsification or reverse phase evaporation of lipids and/or polymers to form a lipid-based system containing the hydrophilic therapeutic agent in the core;
- dissolution of lipids in an organic solvent;
- dissolution of the hydrophilic active ingredient in an ionic solvent;
- hydrating the lipids in the aqueous media with agitation;
- evaporating the organic solvent to form lipid-based liposomal formulations;
- and
- post-formation processing involving purification.
12 more elements
Dependencies are inferred from the claim text.